PHOTO
Dubai: (AETOSWire)- Emirates Hospital-Jumeirah (EHJ), an Emirates Healthcare Company and an internationally recognised 100-bed beacon of progress in the region’s healthcare system, is treating an interesting case. When 7-year-old Maryam from Syria complained of abdominal pain, her parents thought she had an upset stomach. However, repeated complaints led to a consultation with a doctor at EHJ and a diagnosis of Henoch Schonlein Purpura (HSP).
While doctors were investigating the abdominal pain, they noticed that Maryam’s abdominal sonography revealed absent ovaries and an abnormally small uterus. An MRI confirmed their findings.
“When we discovered that Maryam had absent ovaries, we realised that the child was suffering from one of three conditions – external genitalia that look like a girl’s although the person has male sex chromosomes, absent ovary syndrome or a hormonal disorder. Karyotyping revealed the presence of XX chromosomes, proving that the child was female. Her hormonal tests were also clear, probably due to her age,” explained Dr Sripradha Sudarsanam, Specialist Paediatrician at Emirates Hospital-Jumeirah.
Patients with müllerian agenesis have absent ovaries and abnormalities of the uterus, fallopian tubes, vagina and reproductive system. In approximately 30 percent of such cases, there are also renal abnormalities such as a horseshoe kidney or unilateral renal agenesis; 25 percent of patients with this syndrome have skeletal anomalies such as spina bifida or scoliosis.
It is extremely rare for a patient to have isolated absent ovaries and an abnormally small uterus; this condition has been diagnosed in as few as two patients worldwide. Ovaries are extremely important to young girls; they produce the hormones necessary for a healthy reproductive system, strengthen the bones and affect well-being. There is no known cause for the condition, which is usually diagnosed when the patient is between 16 and 20 years of age following a consultation to determine why she has failed to menstruate. More than a decade ago, an 18-year-old girl was diagnosed with the same condition.
Doctors at Emirates Hospital-Jumeirah have created a plan to treat Maryam when she reaches the age of 14. Based on the advice of an endocrinologist, the team will administer hormones in order to simulate the hormonal changes associated with the menstrual cycle and monitor the size of Maryam’s uterus. The aim of the treatment is to promote the development of female secondary sex characteristics and boost Maryam’s confidence.
Maryam was fortunate to receive a diagnosis at such a young age. People who notice any unusual symptoms should consult a doctor.
About Emirates Hospital-Jumeirah:
An Emirates Healthcare Company, Emirates Hospital-Jumeirah is an internationally recognized 100-bed beacon of progress in the region’s healthcare system. It provides personalized, real-time healthcare solutions, and its core values are Simplicity, Accessibility, Agility, and Empathy.
Located on Jumeirah Beach Road alongside the Dubai Canal, Emirates Hospital-Jumeirah is home to some of the world’s leading medical professionals, and it delivers the highest quality of healthcare.
Emirates Hospital-Jumeirah partners with regulators, institutions, insurers, and manufacturers to develop and nurture new ideas and long-term strategies that create positive change in people’s homes and everyday lives. Emirates Hospital-Jumeirah is operated by NMC Healthcare; KBBO Group is the largest single shareholder of NMC.
Emirates Specialty Hospital in Dubai Healthcare City is an Emirates Healthcare Company. A 90-bed facility with superior technology and experienced, internationally-trained staff, Emirates Specialty Hospital delivers an unrivalled range of much-needed specialties.
Emirates Healthcare is a subsidiary of KBBO Group. A leading holding company headquartered in Abu Dhabi, KBBO Group invests in healthcare to safeguard the region’s communities, and to help deliver world-class medical outcomes powering an inclusive and improved quality of life.
Contacts:
SAHARA Communications
Maria F. Tayem,
Senior Account Manager,
+971501714347, +97143298996
m.tayem@saharapr.com / www.saharagcc.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
